Diabetes, obesity, hypertension up mortality in hepatitis C patientsApril 23rd, 2009 - 3:03 pm ICT by ANI
Washington, Apr 23 (ANI): Type 2 diabetes, obesity and hypertension are associated with overall and liver related mortality in hepatitis C (HCV) infected patients, a new research has claimed.
The specific impact of metabolic syndrome on mortality in hepatitis C patients has been revealed by new research to be presented on Sunday April 26 at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark.
In HCV-infected patients, the top three predictors of liver related mortality were having higher body mass index (BMI), presence of insulin resistance (IR) and elevated serum cholesterol. Overall mortality in HCV patients was most linked to metabolic syndrome, higher BMI and hypertension.
Metabolic syndrome is a combination of medical problems that increase risks of cardiovascular disease and diabetes.
Recent data have suggested that metabolic syndrome is associated with adverse outcomes in HCV patients. This study set out to assess which aspects of metabolic syndrome are of most risk to such HCV patients and to quantify their specific impact on mortality.
Professor Zobair Younossi MD, MPH from the Center for Liver Diseases at Inova Fairfax Hospital and the Executive Director of Betty and Guy Beatty’s Center for Integrated Research, Virginia, USA, who led the study, said: “Exploring the risk factors associated with adverse outcomes in HCV patients helps us to better understand the complex nature of this highly prevalent disease.
“This study shows a clear association between key components of metabolic syndrome and mortality in HCV patients and demonstrates the importance of lifestyle improvements and coaching in the management of HCV patients, to potentially minimise the onset and impact of metabolic syndrome and its associated mortality risks.”
Researchers in this study utilised the Third National Health and Nutrition Examination Survey (NHANES III) and Linked Mortality Files. HCV was defined as positive HCV RNA by PCR assay. Subjects without other causes of chronic liver disease such as presumed NAFLD with elevated serum aminotransferases, excessive alcohol use, elevated transferrin saturation and positive hepatitis Bs antigen were designated controls without liver disease. HCV patients were compared to HCV-negative individuals and controls without liver disease using Rao-Scott chi-square statistics.
Adjusted hazard ratios for overall mortality and cause-specific mortality were calculated for HCV patients using persons without HCV. The Cox proportional hazard model was used for calculation of AHR for independent risk factors, and for the presence of HCV as a potential risk factor for overall mortality and cause-specific mortalities.
The cohort included 15,866 individuals with complete data. (ANI)
- Coffee can cure hepatitis C - Jun 08, 2011
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- Obese patients at higher risk from major complications after surgery - Apr 19, 2011
- Genetic variation linked to liver cirrhosis in alcoholic Caucasians identified - Dec 17, 2010
- Non-alcoholic steatohepatitis linked to liver cancer - May 26, 2010
- Pine bark extract improves kidney function in patients with metabolic syndrome - Mar 02, 2011
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- Mortality rate down, but BP still cause for concern - Apr 27, 2011
- Molecular switch behind development of fatty liver disease identified - Apr 06, 2011
- Peg or two lowers risk of liver disease - Apr 23, 2012
- Metabolic syndrome may up liver cancer risk - Apr 04, 2011
- Hepatitis C vaccine undergoing trials - Aug 16, 2012
- Non-alcoholic fatty liver disease patients at greater risk - Jan 28, 2010
- Why some people develop medical complications of obesity while others don't - Mar 11, 2011
- Hepatitis C virus infection linked to fat enzyme in liver cells - Oct 11, 2010
Tags: body mass index, body mass index bmi, copenhagen denmark, easl, hcv patients, health and nutrition, hepatitis c, hepatitis c patients, inova fairfax hospital, insulin resistance, integrated research, lifestyle improvements, liver diseases, metabolic syndrome, mortality risks, nutrition examination survey, prevalent disease, s center, serum cholesterol, type 2 diabetes